Log In
Print
BCIQ
Print
Print this Print this
 

XT-101

  Manage Alerts
Collapse Summary General Information
Company Xalud Therapeutics Inc.
DescriptionEncapsulated formulation of expression plasmid DNA encoding human interleukin-10 (IL-10).
Molecular Target
Mechanism of Action 
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationPain
Indication DetailsTreat neuropathic and chronic pain
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today